SCOR:NASDAQcomScore, Inc. Analysis
Data as of 2026-09-01 - not real-time
$5.25
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $5.25, comScore, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. Across the trailing 30 sessions it lost 29.5%. Relative strength is 35.0 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $4.60 up to resistance at $7.73.
Valuation screens as undervalued: a P/E of 0.7 sits below the sector average of 35.8. The average analyst target implies 4.8% below today's level. Revenue is contracting at 11.3% on a -5.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 78.9%, a beta of 0.64 and a maximum drawdown of 46.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.
Valuation screens as undervalued: a P/E of 0.7 sits below the sector average of 35.8. The average analyst target implies 4.8% below today's level. Revenue is contracting at 11.3% on a -5.1% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 78.9%, a beta of 0.64 and a maximum drawdown of 46.1%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 1 out of 10.
Top Market Events
Yahoo Finance19dcomScore, Inc. SCOR Q2 FY2026 earnings call transcriptComscore reported Q2 2026 revenue of $79.2M, down...RESTON, Va., July 29, 2026 GLOBE NEWSWIRE -- Comscore, Inc. Nasdaq: SCOR , a trusted partner for planning, transacting...Seeking Alpha18dComscore outlines $20M-$25M annual run-rate cost savings as it forecasts $315M-$325M 2026 revenue"Our...
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 7.16
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 0.7 versus sector average of 35.8
- Trading below the 200-day average of 7.16
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 0.7 versus sector average of 35.8
- Negative profit margin of -5.1%
- Negative return on equity of -9.6%
Key Metrics & Analysis
Financial Health
Revenue Growth-11.30%
Profit Margin-5.06%
P/E Ratio0.7
ROE-9.62%
ROA-0.94%
Debt/Equity5.20
P/B Ratio0.9
Op. Cash Flow$20.8M
Free Cash Flow$-16102875
Industry P/E35.8
Technical Analysis
TrendBearish
RSI35.0
Support$4.60
Resistance$7.73
MA 20$6.03
MA 50$6.75
MA 200$7.16
MACDBearish
VolumeIncreasing
Fear & Greed Index93.07
Valuation
Fair Value$13.27
Target Price$5.00
Upside/Downside-4.76%
GradeUndervalued
TypeValue
Risk Assessment
Beta0.64
Volatility78.87%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.